RESUMEN
Objective: This article reports the range of motion, failure rate, and complications of patients with extensor mechanism injury after total knee arthroplasty (TKA) treated with extensor mechanism allograft with mid-term follow-up. Methods: Patients undergoing post-ATJ extensor mechanism transplantation from 2009 to 2018 were retrospectively evaluated. Demographics, the reason for transplantation, elapsed time from arthroplasty to transplantation, related surgical factors, immobilization time, range of motion, transplant failure, and complications were collected. The minimum follow-up was 24 months. Results: Twenty patients were evaluated. The mean follow-up was 70.8 +/- 33.6 months. The most common cause of extensor mechanism rupture was traumatic in 10 (50%) cases. Six patients underwent associated surgeries, one case of medial ligament complex reconstruction, and 5 cases of TKA revision. Eleven patients (55%) had transplant-related complications. The most common complication was an infection. Five cases presented transplant failure. Conclusion: Patients who underwent extensor mechanism allograft transplantation after total knee arthroplasty had a 25% failure rate with a mean follow-up of 6 years. Although there was no loss of flexion with the procedure and prolonged immobilization, the complication rate was not low. Level of evidence IV; case series .
Objetivo: O objetivo do estudo foi relatar amplitude de movimento, taxa de falha e complicações de pacientes com lesão do mecanismo extensor após artroplastia total do joelho (ATJ) tratados com aloenxerto do mecanismo extensor com acompanhamento no médio prazo. Métodos: Pacientes submetidos a transplante de mecanismo extensor pós-ATJ de 2009 a 2018 foram avaliados retrospectivamente. Foram avaliados dados demográficos, motivo do transplante, tempo decorrido da artroplastia ao transplante, fatores cirúrgicos relacionados, tempo de imobilização, arco de movimento, falha do transplante e complicações. O acompanhamento mínimo foi de 24 meses. Resultados: Vinte pacientes foram avaliados. O tempo médio de acompanhamento foi de 70,8 +/- 33,6 meses. A causa mais comum de ruptura do mecanismo extensor foi traumática em 10 (50%) casos. Seis pacientes foram submetidos a cirurgias associadas, um caso de reconstrução do complexo ligamentar medial e 5 casos de revisão de ATJ. Onze pacientes (55%) tiveram complicações relacionadas ao transplante. A complicação mais comum foi a infecção. Cinco casos apresentaram falha do transplante. Conclusão: Pacientes submetidos a transplante de aloenxerto de mecanismo extensor após artroplastia total de joelho apresentam taxa de falha de 25% com seguimento médio de 6 anos. Embora não tenha havido perda de flexão com o procedimento e com a imobilização prolongada, o índice de complicações não foi baixo. Nível de evidênvia IV; série de casos .
RESUMEN
ABSTRACT Objective: This article reports the range of motion, failure rate, and complications of patients with extensor mechanism injury after total knee arthroplasty (TKA) treated with extensor mechanism allograft with mid-term follow-up. Methods: Patients undergoing post-ATJ extensor mechanism transplantation from 2009 to 2018 were retrospectively evaluated. Demographics, the reason for transplantation, elapsed time from arthroplasty to transplantation, related surgical factors, immobilization time, range of motion, transplant failure, and complications were collected. The minimum follow-up was 24 months. Results: Twenty patients were evaluated. The mean follow-up was 70.8 +/- 33.6 months. The most common cause of extensor mechanism rupture was traumatic in 10 (50%) cases. Six patients underwent associated surgeries, one case of medial ligament complex reconstruction, and 5 cases of TKA revision. Eleven patients (55%) had transplant-related complications. The most common complication was an infection. Five cases presented transplant failure. Conclusion: Patients who underwent extensor mechanism allograft transplantation after total knee arthroplasty had a 25% failure rate with a mean follow-up of 6 years. Although there was no loss of flexion with the procedure and prolonged immobilization, the complication rate was not low. Level of evidence IV; case series .
RESUMO Objetivo: O objetivo do estudo foi relatar amplitude de movimento, taxa de falha e complicações de pacientes com lesão do mecanismo extensor após artroplastia total do joelho (ATJ) tratados com aloenxerto do mecanismo extensor com acompanhamento no médio prazo. Métodos: Pacientes submetidos a transplante de mecanismo extensor pós-ATJ de 2009 a 2018 foram avaliados retrospectivamente. Foram avaliados dados demográficos, motivo do transplante, tempo decorrido da artroplastia ao transplante, fatores cirúrgicos relacionados, tempo de imobilização, arco de movimento, falha do transplante e complicações. O acompanhamento mínimo foi de 24 meses. Resultados: Vinte pacientes foram avaliados. O tempo médio de acompanhamento foi de 70,8 +/- 33,6 meses. A causa mais comum de ruptura do mecanismo extensor foi traumática em 10 (50%) casos. Seis pacientes foram submetidos a cirurgias associadas, um caso de reconstrução do complexo ligamentar medial e 5 casos de revisão de ATJ. Onze pacientes (55%) tiveram complicações relacionadas ao transplante. A complicação mais comum foi a infecção. Cinco casos apresentaram falha do transplante. Conclusão: Pacientes submetidos a transplante de aloenxerto de mecanismo extensor após artroplastia total de joelho apresentam taxa de falha de 25% com seguimento médio de 6 anos. Embora não tenha havido perda de flexão com o procedimento e com a imobilização prolongada, o índice de complicações não foi baixo. Nível de evidênvia IV; série de casos .
RESUMEN
BACKGROUND: Numerous causes of infection in arthroplasties are related to biofilm formation on implant surfaces. In order to circumvent this problem, new alternatives to prevent bacterial adhesion biosurfactants-based are emerging due to low toxicity, biodegradability and antimicrobial activity of several biosurfactants. We revised all patents relating to biosurfactants of applicability in orthopedic implants. METHODS: This work aims to evaluate the capability of a lipopeptide produced by Bacillus subtilis ATCC 19659 isolates acting as inhibitors of the adhesion of Escherichia coli ATCC 25922 and Staphylococcus aureus ATCC 29213 onto titanium and stainless steel surfaces and its antimicrobial activity. RESULTS: The adhesion of the strains to the stainless-steel surface was higher than that of titanium. Preconditioning of titanium and stainless-steel surfaces with 10 mg mL-1 lipopeptide reduced the adhesion of E. coli by up to 93% and the adhesion of S. aureus by up to 99.9%, suggesting the strong potential of lipopeptides in the control of orthopedic infections. The minimal inhibitory concentration and minimum bactericidal concentration were 10 and 240 µg mL-1 for E. coli and S. aureus, respectively. CONCLUSION: The lipopeptide produced by Bacillus subtilis ATCC 19659 presented high biotechnological application in human health against orthopedic implants infections.